{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:31:09Z","timestamp":1774679469978,"version":"3.50.1"},"reference-count":60,"publisher":"Japanese Association of Rehabilitation Medicine","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PRM"],"published-print":{"date-parts":[[2026]]},"DOI":"10.2490\/prm.20260012","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T22:22:48Z","timestamp":1774390968000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Combined Nutritional and Exercise Interventions for Cachexia in                    Chronic Diseases: A Systematic Review and Meta-analysis Limited to Cancer                    Cachexia"],"prefix":"10.2490","volume":"11","author":[{"given":"Masatsugu","family":"Okamura","sequence":"first","affiliation":[{"name":"Berlin Institute of Health Center for Regenerative Therapies                            (BCRT), Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin,                            Germany"},{"name":"Department of Rehabilitation Medicine, School of Medicine,                            Yokohama City University, Yokohama, Japan"},{"name":"Change Nutrition from Rehabilitation \u2013 Virtual Laboratory                            (CNR), Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Shirado","sequence":"additional","affiliation":[{"name":"Change Nutrition from Rehabilitation \u2013 Virtual Laboratory                            (CNR), Niigata, Japan"},{"name":"Department of Rehabilitation, Aso Iizuka Hospital, Iizuka,                            Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Shirai","sequence":"additional","affiliation":[{"name":"Change Nutrition from Rehabilitation \u2013 Virtual Laboratory                            (CNR), Niigata, Japan"},{"name":"Department of Rehabilitation, Niigata Rinko Hospital, Niigata,                            Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Yagi","sequence":"additional","affiliation":[{"name":"Change Nutrition from Rehabilitation \u2013 Virtual Laboratory                            (CNR), Niigata, Japan"},{"name":"Department of Rehabilitation, Hattori Hospital, Miki,                            Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Inoue","sequence":"additional","affiliation":[{"name":"Change Nutrition from Rehabilitation \u2013 Virtual Laboratory                            (CNR), Niigata, Japan"},{"name":"Department of Physical Therapy, Niigata University of Health                            and Welfare, Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Change Nutrition from Rehabilitation \u2013 Virtual Laboratory                            (CNR), Niigata, Japan"},{"name":"Graduate School of Medicine, Kobe University, Hyogo,                            Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin Stella","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences, School of Life Course and                            Population Sciences, Faculty of Life Sciences and Medicine, King\u2019s                            College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Von haehling","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Pneumology, University Medical                            Center G\u00f6ttingen, G\u00f6ttingen, Germany; German Center for Cardiovascular Research (DZHK), partner site G\u00f6ttingen,                            G\u00f6ttingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Springer","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health Center for Regenerative Therapies                            (BCRT), Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin, Berlin,                            Germany; German Center for Cardiovascular Research (DZHK), partner site                            Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CVK), Charit\u00e9 \u2013 Universit\u00e4tsmedizin                            Berlin, Berlin, Germany; Berlin Institute of Health Center                            for Regenerative Therapies (BCRT), Charit\u00e9 \u2013 Universit\u00e4tsmedizin                            Berlin, Berlin, Germany; German Center for Cardiovascular Research                            (DZHK), partner site Berlin, Berlin, Germany"},{"name":"Institute of Heart Diseases, Wroclaw Medical University,                            Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Momosaki","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Mie University Graduate                            School of Medicine, Tsu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1338","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Evans WJ, Morley JE, Argil\u00e9s J, Bales C,                    Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks                    D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan                    M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD: Cachexia: a new                    definition. Clin Nutr 2008;27:793\u2013799. PMID:18718696,                    https:\/\/doi.org\/10.1016\/j.clnu.2008.06.013","DOI":"10.1016\/j.clnu.2008.06.013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Anker MS, Holcomb R, Muscaritoli M, von                    Haehling S, Haverkamp W, Jatoi A, Morley JE, Strasser F, Landmesser U, Coats AJ,                    Anker SD: Orphan disease status of cancer cachexia in the USA and in the                    European Union: a systematic review. J Cachexia Sarcopenia Muscle 2019;10:22\u201334.                    PMID:30920776, https:\/\/doi.org\/10.1002\/jcsm.12402","DOI":"10.1002\/jcsm.12402"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Carson MA, Reid J, Hill L, Dixon L,                    Donnelly P, Slater P, Hill A, Piper SE, McDonagh TA, Fitzsimons D: Exploring the                    prevalence, impact and experience of cardiac cachexia in patients with advanced                    heart failure and their caregivers: a sequential phased study. Palliat Med                    2022;36:1118\u20131128. PMID:35729767,                    https:\/\/doi.org\/10.1177\/02692163221101748","DOI":"10.1177\/02692163221101748"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Amitani M, Asakawa A, Amitani H, Inui A:                    Control of food intake and muscle wasting in cachexia. Int J Biochem Cell Biol                    2013;45:2179\u20132185. PMID:23911307,                    https:\/\/doi.org\/10.1016\/j.biocel.2013.07.016","DOI":"10.1016\/j.biocel.2013.07.016"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sadeghi M, Keshavarz-Fathi M, Baracos V,                    Arends J, Mahmoudi M, Rezaei N: Cancer cachexia: diagnosis, assessment, and                    treatment. Crit Rev Oncol Hematol 2018;127:91\u2013104. PMID:29891116,                    https:\/\/doi.org\/10.1016\/j.critrevonc.2018.05.006","DOI":"10.1016\/j.critrevonc.2018.05.006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lena A, Hadzibegovic S, von Haehling S,                    Springer J, Coats AJ, Anker MS: Sarcopenia and cachexia in chronic diseases:                    from mechanisms to treatment. Pol Arch Intern Med 2021;131:16135. PMID:34775741,                    https:\/\/doi.org\/10.20452\/pamw.16135","DOI":"10.20452\/pamw.16135"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Roeland EJ, Bohlke K, Baracos VE, Bruera                    E, del Fabbro E, Dixon S, Fallon M, Herrstedt J, Lau H, Platek M, Rugo HS,                    Schnipper HH, Smith TJ, Tan W, Loprinzi CL: Management of cancer cachexia: ASCO                    guideline. J Clin Oncol 2020;38:2438\u20132453. PMID:32432946,                    https:\/\/doi.org\/10.1200\/JCO.20.00611","DOI":"10.1200\/JCO.20.00611"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Slee A, Reid J: Exercise and nutrition                    interventions for renal cachexia. Curr Opin Clin Nutr Metab Care                    2024;27:219\u2013225. PMID:38386361,                    https:\/\/doi.org\/10.1097\/MCO.0000000000001022","DOI":"10.1097\/MCO.0000000000001022"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Arai H, Maeda K, Wakabayashi H, Naito T,                    Konishi M, Assantachai P, Auyeung WT, Chalermsri C, Chen W, Chew J, Chou MY, Hsu                    CC, Hum A, Hwang IG, Kaido T, Kang L, Kamaruzzaman SB, Kim M, Lee JS, Lee WJ,                    Liang CK, Lim WS, Lim JY, Lim YP, Lo RS, Ong T, Pan WH, Peng LN, Pramyothin P,                    Razalli NH, Saitoh M, Shahar S, Shi HP, Tung HH, Uezono Y, von Haehling S, Won                    CW, Woo J, Chen LK: Diagnosis and outcomes of cachexia in Asia: working                    consensus report from the Asian Working Group for Cachexia. J Cachexia                    Sarcopenia Muscle 2023;14:1949\u20131958. PMID:37667992,                    https:\/\/doi.org\/10.1002\/jcsm.13323","DOI":"10.1002\/jcsm.13323"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wakabayashi H, Sakuma K: Rehabilitation                    nutrition for sarcopenia with disability: a combination of both rehabilitation                    and nutrition care management. J Cachexia Sarcopenia Muscle 2014;5:269\u2013277.                    PMID:25223471, https:\/\/doi.org\/10.1007\/s13539-014-0162-x","DOI":"10.1007\/s13539-014-0162-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wakabayashi H: Rehabilitation nutrition                    in general and family medicine. J Gen Fam Med 2017;18:153\u2013154. PMID:29264014,                    https:\/\/doi.org\/10.1002\/jgf2.116","DOI":"10.1002\/jgf2.116"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kakehi S, Wakabayashi H, Inuma H, Inose                    T, Shioya M, Aoyama Y, Hara T, Uchimura K, Tomita K, Okamoto M, Yoshida M,                    Yokota S, Suzuki H: Rehabilitation nutrition and exercise therapy for                    sarcopenia. World J Mens Health 2022;40:1\u201310. PMID:33831974,                    https:\/\/doi.org\/10.5534\/wjmh.200190","DOI":"10.5534\/wjmh.200190"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tisdale MJ: Cachexia in cancer patients.                    Nat Rev Cancer 2002;2:862\u2013871. PMID:12415256,                    https:\/\/doi.org\/10.1038\/nrc927","DOI":"10.1038\/nrc927"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vest AR, Chan M, Deswal A, Givertz MM,                    Lekavich C, Lennie T, Litwin SE, Parsly L, Rodgers JE, Rich MW, Schulze PC,                    Slader A, Desai A: Nutrition, obesity, and cachexia in patients with heart                    failure: a consensus statement from the Heart Failure Society of America                    Scientific Statements Committee. J Card Fail 2019;25:380\u2013400. PMID:30877038,                    https:\/\/doi.org\/10.1016\/j.cardfail.2019.03.007","DOI":"10.1016\/j.cardfail.2019.03.007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kataoka Y, Tsujimoto Y, Banno M, Taito S,                    So R, Watanabe J, Shiroshita A: Protocol template for intervention review.                    Protocols.io. 2022.                    https:\/\/www.protocols.io\/view\/protocol-template-for-intervention-review-81wgbpb41vpk\/v2.","DOI":"10.17504\/protocols.io.81wgbpb41vpk\/v2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Page MJ, McKenzie JE, Bossuyt PM, Boutron                    I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R,                    Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson                    E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting                    P, Moher D: The PRISMA 2020 statement: an updated guideline for reporting                    systematic reviews. BMJ 2021;372:n71. PMID:33782057,                    https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fearon K, Strasser F, Anker SD, Bosaeus                    I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis                    M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S,                    Baracos VE: Definition and classification of cancer cachexia: an international                    consensus. Lancet Oncol 2011;12:489\u2013495. PMID:21296615,                    https:\/\/doi.org\/10.1016\/S1470-2045(10)70218-7","DOI":"10.1016\/S1470-2045(10)70218-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Uster A, Ruehlin M, Mey S, Gisi D, Knols                    R, Imoberdorf R, Pless M, Ballmer PE: Effects of nutrition and physical exercise                    intervention in palliative cancer patients: a randomized controlled trial. Clin                    Nutr 2018;37:1202\u20131209. PMID:28651827,                    https:\/\/doi.org\/10.1016\/j.clnu.2017.05.027","DOI":"10.1016\/j.clnu.2017.05.027"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hall CC, Skipworth RJ, Blackwood H, Brown                    D, Cook J, Diernberger K, Dixon E, Gibson V, Graham C, Hall P, Haraldsdottir E,                    Hopkinson J, Lloyd A, Maddocks M, Norris L, Tuck S, Fallon MT, Laird BJ: A                    randomized, feasibility trial of an exercise and nutrition\u2010based rehabilitation                    programme (ENeRgy) in people with cancer. J Cachexia Sarcopenia Muscle                    2021;12:2034\u20132044. PMID:34612012,                    https:\/\/doi.org\/10.1002\/jcsm.12806","DOI":"10.1002\/jcsm.12806"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Calder PC, Laviano A, Lonnqvist F,                    Muscaritoli M, \u00d6hlander M, Schols A: Targeted medical nutrition for cachexia in                    chronic obstructive pulmonary disease: a randomized, controlled trial. J                    Cachexia Sarcopenia Muscle 2018;9:28\u201340. PMID:28891198,                    https:\/\/doi.org\/10.1002\/jcsm.12228","DOI":"10.1002\/jcsm.12228"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Naito T, Mitsunaga S, Miura S, Tatematsu                    N, Inano T, Mouri T, Tsuji T, Higashiguchi T, Inui A, Okayama T, Yamaguchi T,                    Morikawa A, Mori N, Takahashi T, Strasser F, Omae K, Mori K, Takayama K:                    Feasibility of early multimodal interventions for elderly patients with advanced                    pancreatic and non\u2010small\u2010cell lung cancer. J Cachexia Sarcopenia Muscle                    2019;10:73\u201383. PMID:30334618,                    https:\/\/doi.org\/10.1002\/jcsm.12351","DOI":"10.1002\/jcsm.12351"},{"key":"22","unstructured":"22. Okamura M, Shirado K, Shirai N, Yagi T,                    Inoue T, Ogawa M, Sullivan ES, von Haehling S, Springer J, Anker SD, Momosaki R:                    Combined nutritional and exercise interventions for cachexia in chronic                    diseases: a systematic review. 16th International Conference on Cachexia,                    Sarcopenia and Muscle Wasting. 2023.                    https:\/\/society-scwd.org\/wp-content\/uploads\/2023\/06\/FINAL_Cachexia_2023.pdf."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Arends J, Strasser F, Gonella S, Solheim                    TS, Madeddu C, Ravasco P, Buonaccorso L, de van der Schueren MA, Baldwin C,                    Chasen M, Ripamonti CI, ESMO Guidelines Committee: Cancer cachexia in adult                    patients: ESMO Clinical Practice Guidelines. ESMO Open 2021;6:100092.                    PMID:34144781, https:\/\/doi.org\/10.1016\/j.esmoop.2021.100092","DOI":"10.1016\/j.esmoop.2021.100092"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Rogers ES, Sasidharan R, Sequeira GM,                    Wood MR, Bird SP, Keogh JW, Arroll B, Stewart J, MacLeod RD: A multi\u2010targeted                    treatment approach to cancer cachexia: Auckland\u2019s Cancer Cachexia evaluating                    Resistance Training (ACCeRT) trial. JCSM Rapid Commun 2020;3:11\u201324.                    https:\/\/doi.org\/10.1002\/rco2.10","DOI":"10.1002\/rco2.10"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Sterne JA, Savovi\u0107 J, Page MJ, Elbers RG,                    Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson                    JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ,                    Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA,                    Tilling K, White IR, Whiting PF, Higgins JP: RoB 2: a revised tool for assessing                    risk of bias in randomised trials. BMJ 2019;366:l4898. PMID:31462531,                    https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"26","unstructured":"26. Higgins JP, Chandler J, Cumpston M, Li T,                    Page MJ, Welch VA: Cochrane handbook for systematic reviews of interventions,                    version 6.3. Cochrane. 2022."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist                    G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, deBeer H, Jaeschke R, Rind D,                    Meerpohl J, Dahm P, Sch\u00fcnemann HJ: GRADE guidelines: 1. Introduction\u2014GRADE                    evidence profiles and summary of findings tables. J Clin Epidemiol                    2011;64:383\u2013394. PMID:21195583,                    https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Solheim TS, Laird BJ, Balstad TR, Stene                    GB, Bye A, Johns N, Pettersen CH, Fallon M, Fayers P, Fearon K, Kaasa S: A                    randomized phase II feasibility trial of a multimodal intervention for the                    management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia                    Muscle 2017;8:778\u2013788. PMID:28614627,                    https:\/\/doi.org\/10.1002\/jcsm.12201","DOI":"10.1002\/jcsm.12201"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kim BH, Maeng CH, Chon J, Kang WS, Kang                    K, Woo M, Hong IK, Lee J, Lee KY: Effect of multimodal intervention care on                    cachexia in patients with advanced cancer compared to conventional management                    (MIRACLE): an open-label, parallel, randomized, phase 2 trial. J Clin                    Oncol2023;41:e24135.","DOI":"10.1200\/JCO.2023.41.16_suppl.e24135"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Haug M, Schwappacher R, Pollmann C,                    Ritter P, Michael M, Hermann HJ, Gr\u00fctzmann R, Mittelst\u00e4dt A, Neurath MF, Zopf Y,                    Friedrich O: Effects of adjuvant exercise and nutrition therapy on muscle fibre                    biomechanics in gastrointestinal cancer patients. Cancers (Basel) 2024;16:1608.                    PMID:38672689, https:\/\/doi.org\/10.3390\/cancers16081608","DOI":"10.3390\/cancers16081608"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Solheim TS, Laird BJ, Balstad TR, Stene                    GB, Baracos V, Bye A, Dajani O, Hendifar AE, Strasser F, Chasen MR, Maddocks M,                    Simpson MR, Skovlund E, Griffiths GO, Hicks J, Graham JS, Kyle F, Bowden J,                    Fallon MT, Kaasa S: Results from a randomised, open-label trial of a multimodal                    intervention (exercise, nutrition and anti-inflammatory medication) plus                    standard care versus standard care alone to attenuate cachexia in patients with                    advanced cancer undergoing chemotherapy. J Clin Oncol                    2024;42:LBA12007.","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA12007"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Maeng CH, Kim BH, Chon J, Kang WS, Kang                    K, Woo M, Hong IK, Lee J, Lee KY: Effect of multimodal intervention care on                    cachexia in patients with advanced cancer compared to conventional management                    (MIRACLE): an open-label, parallel, randomized, phase 2 trial. Trials                    2022;23:281. PMID:35410294,                    https:\/\/doi.org\/10.1186\/s13063-022-06221-z","DOI":"10.1186\/s13063-022-06221-z"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Poisson J, Martinez-Tapia C, Heitz D,                    Geiss R, Albrand G, Falandry C, Gisselbrecht M, Couderc AL, Boulahssass R, Liuu                    E, Boudou-Rouquette P, Chah Wakilian A, Gaxatte C, Pamoukdjian F, de Decker L,                    Antoine V, Cattenoz C, Solem-Laviec H, Guillem O, Medjenah H, Natella PA,                    Canou\u00ef-Poitrine F, Laurent M, Paillaud E: Prevalence and prognostic impact of                    cachexia among older patients with cancer: a nationwide cross\u2010sectional survey                    (NutriAgeCancer). J Cachexia Sarcopenia Muscle 2021;12:1477\u20131488. PMID:34519440,                    https:\/\/doi.org\/10.1002\/jcsm.12776","DOI":"10.1002\/jcsm.12776"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Brown LR, Sousa MS, Yule MS, Baracos VE,                    McMillan DC, Arends J, Balstad TR, Bye A, Dajani O, Dolan RD, Fallon MT, Greil                    C, Hjermstad MJ, Jakobsen G, Maddocks M, McDonald J, Ottestad IO, Phillips I,                    Sayers J, Simpson MR, Vagnildhaug OM, Solheim TS, Laird BJ, Skipworth RJ, Cancer                    Cachexia Endpoints Working Group: Body weight and composition endpoints in                    cancer cachexia clinical trials: systematic review 4 of the cachexia endpoints                    series. J Cachexia Sarcopenia Muscle 2024;15:816\u2013852. PMID:38738581,                    https:\/\/doi.org\/10.1002\/jcsm.13478","DOI":"10.1002\/jcsm.13478"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Peixoto da Silva S, Santos JMO, Costa E                    Silva MP, Gil da Costa RM, Medeiros R: Cancer cachexia and its pathophysiology:                    links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle                    2020;11:619\u2013635. PMID:32142217,                    https:\/\/doi.org\/10.1002\/jcsm.12528","DOI":"10.1002\/jcsm.12528"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Bielecka-Dabrowa A, Ebner N, dos Santos                    MR, Ishida J, Hasenfuss G, von Haehling S: Cachexia, muscle wasting, and frailty                    in cardiovascular disease. Eur J Heart Fail 2020;22:2314\u20132326. PMID:32949422,                    https:\/\/doi.org\/10.1002\/ejhf.2011","DOI":"10.1002\/ejhf.2011"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Hanna RM, Ghobry L, Wassef O, Rhee CM,                    Kalantar-Zadeh K: A practical approach to nutrition, protein-energy wasting,                    sarcopenia, and cachexia in patients with chronic kidney disease. Blood Purif                    2020;49:202\u2013211. PMID:31851983,                    https:\/\/doi.org\/10.1159\/000504240","DOI":"10.1159\/000504240"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ferrer M, Anthony TG, Ayres JS, Biffi G,                    Brown JC, Caan BJ, Cespedes Feliciano EM, Coll AP, Dunne RF, Goncalves MD,                    Grethlein J, Heymsfield SB, Hui S, Jamal-Hanjani M, Lam JM, Lewis DY, McCandlish                    D, Mustian KM, O\u2019Rahilly S, Perrimon N, White EP, Janowitz T: Cachexia: a                    systemic consequence of progressive, unresolved disease. Cell                    2023;186:1824\u20131845. PMID:37116469,                    https:\/\/doi.org\/10.1016\/j.cell.2023.03.028","DOI":"10.1016\/j.cell.2023.03.028"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Uchiyama K, Adachi K, Muraoka K, Nakayama                    T, Oshida T, Yasuda M, Hishikawa A, Minakuchi H, Miyashita K, Tokuyama H, Wakino                    S, Itoh H: Home\u2010based aerobic exercise and resistance training for severe                    chronic kidney disease: a randomized controlled trial. J Cachexia Sarcopenia                    Muscle 2021;12:1789\u20131802. PMID:34554649,                    https:\/\/doi.org\/10.1002\/jcsm.12775","DOI":"10.1002\/jcsm.12775"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Wakabayashi H, Arai H, Inui A: The                    regulatory approval of anamorelin for treatment of cachexia in patients with                    non\u2010small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal                    cancer in Japan: facts and numbers. J Cachexia Sarcopenia Muscle 2021;12:14\u201316.                    PMID:33382205, https:\/\/doi.org\/10.1002\/jcsm.12675","DOI":"10.1002\/jcsm.12675"},{"key":"41","unstructured":"41. European Medicines Agency: Adlumiz. 2017.                    . Accessed 1st July, 2025."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Prado CM, Sawyer MB, Ghosh S, Lieffers                    JR, Esfandiari N, Antoun S, Baracos VE: Central tenet of cancer cachexia                    therapy: do patients with advanced cancer have exploitable anabolic potential?                    Am J Clin Nutr 2013;98:1012\u20131019. PMID:23966429,                    https:\/\/doi.org\/10.3945\/ajcn.113.060228","DOI":"10.3945\/ajcn.113.060228"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Baracos VE, Martin L, Korc M, Guttridge                    DC, Fearon KC: Cancer-associated cachexia. Nat Rev Dis Primers 2018;4:17105.                    PMID:29345251, https:\/\/doi.org\/10.1038\/nrdp.2017.105","DOI":"10.1038\/nrdp.2017.105"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Del Fabbro E: Combination therapy in                    cachexia. Ann Palliat Med 2019;8:59\u201366. PMID:30180745,                    https:\/\/doi.org\/10.21037\/apm.2018.08.05","DOI":"10.21037\/apm.2018.08.05"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Prado CM, Laviano A, Gillis C, Sung AD,                    Gardner M, Yalcin S, Dixon S, Newman SM, Bastasch MD, Sauer AC, Hegazi R, Chasen                    MR: Examining guidelines and new evidence in oncology nutrition: a position                    paper on gaps and opportunities in multimodal approaches to improve patient                    care. Support Care Cancer 2022;30:3073\u20133083. PMID:34811570,                    https:\/\/doi.org\/10.1007\/s00520-021-06661-4","DOI":"10.1007\/s00520-021-06661-4"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Del Fabbro E, Hui D, Dalal S, Dev R,                    Nooruddin ZI, Bruera E: Clinical outcomes and contributors to weight loss in a                    cancer cachexia clinic. J Palliat Med 2011;14:1004\u20131008. PMID:21793729,                    https:\/\/doi.org\/10.1089\/jpm.2011.0098","DOI":"10.1089\/jpm.2011.0098"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Granda-Cameron C, Lynch MP: Clinical                    framework for quality improvement of cancer cachexia. Asia Pac J Oncol Nurs                    2018;5:369\u2013376. PMID:30271818,                    https:\/\/doi.org\/10.4103\/apjon.apjon_18_18","DOI":"10.4103\/apjon.apjon_18_18"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Bland KA, Zopf EM, Harrison M, Ely M,                    Cormie P, Liu E, Dowd A, Martin P: Prognostic markers of overall survival in                    cancer patients attending a cachexia support service: an evaluation of                    clinically assessed physical function, malnutrition and inflammatory status.                    Nutr Cancer 2021;73:1400\u20131410. PMID:32757683,                    https:\/\/doi.org\/10.1080\/01635581.2020.1800765","DOI":"10.1080\/01635581.2020.1800765"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Bland KA, Harrison M, Zopf EM, Sousa MS,                    Currow DC, Ely M, Agar M, Butcher BE, Vaughan V, Dowd A, Martin P: Quality of                    life and symptom burden improve in patients attending a multidisciplinary                    clinical service for cancer cachexia: a retrospective observational review. J                    Pain Symptom Manage 2021;62:e164\u2013e176. PMID:33652095,                    https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.02.034","DOI":"10.1016\/j.jpainsymman.2021.02.034"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Bowers M, Petrasso C, McLuskie A, Bayly                    J, Barry JAL, Higginson IJ, Maddocks M: Multicomponent interventions for adults                    with cancer cachexia: a systematic review. J Cachexia Sarcopenia Muscle                    2025;16:e13716. PMID:40012451,                    https:\/\/doi.org\/10.1002\/jcsm.13716","DOI":"10.1002\/jcsm.13716"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51.Dewey A, Baughan C, Dean TP, Higgins B                    andJohnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils)                    for the treatment of cancer cachexia. Cochrane Database Syst Rev                    2007;2007:CD004597 PMID:17253515,                    https:\/\/doi.org\/10.1002\/14651858.CD004597.pub2","DOI":"10.1002\/14651858.CD004597.pub2"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Brook MS, Wilkinson DJ, Atherton PJ: An                    update on nutrient modulation in the management of disease-induced muscle                    wasting: evidence from human studies. Curr Opin Clin Nutr Metab Care                    2020;23:174\u2013180. PMID:32175954,                    https:\/\/doi.org\/10.1097\/MCO.0000000000000652","DOI":"10.1097\/MCO.0000000000000652"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Grande AJ, Silva V, Sawaris Neto L,                    Teixeira Basmage JP, Peccin MS, Maddocks M: Exercise for cancer cachexia in                    adults. Cochrane Database Syst Rev 2021;3:CD010804. PMID:33735441,                    https:\/\/doi.org\/10.1002\/14651858.CD010804.pub3","DOI":"10.1002\/14651858.CD010804.pub3"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Cortiula F, Hendriks LE, van de Worp WR,                    Schols AM, Vaes RD, Langen RC, De Ruysscher D: Physical exercise at the                    crossroad between muscle wasting and the immune system: implications for lung                    cancer cachexia. J Cachexia Sarcopenia Muscle 2022;13:55\u201367. PMID:35014216,                    https:\/\/doi.org\/10.1002\/jcsm.12900","DOI":"10.1002\/jcsm.12900"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Fletcher GF, Ades PA, Kligfield P, Arena                    R, Balady GJ, Bittner VA, Coke LA, Fleg JL, Forman DE, Gerber TC, Gulati M,                    Madan K, Rhodes J, Thompson PD, Williams MA, American Heart Association                    Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on                    Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism,                    Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and                    Prevention: Exercise standards for testing and training: a scientific statement                    from the American Heart Association. Circulation 2013;128:873\u2013934.                    PMID:23877260, https:\/\/doi.org\/10.1161\/CIR.0b013e31829b5b44","DOI":"10.1161\/CIR.0b013e31829b5b44"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Skivington K, Matthews L, Simpson SA,                    Craig P, Baird J, Blazeby JM, Boyd KA, Craig N, French DP, McIntosh E, Petticrew                    M, Rycroft-Malone J, White M, Moore L: A new framework for developing and                    evaluating complex interventions: update of Medical Research Council guidance.                    BMJ 2021;374:n2061. PMID:34593508,                    https:\/\/doi.org\/10.1136\/bmj.n2061","DOI":"10.1136\/bmj.n2061"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Laird BJ, Balstad TR, Solheim TS:                    Endpoints in clinical trials in cancer cachexia: where to start? Curr Opin                    Support Palliat Care 2018;12:445\u2013452. PMID:30299325,                    https:\/\/doi.org\/10.1097\/SPC.0000000000000387","DOI":"10.1097\/SPC.0000000000000387"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Crawford J: What are the criteria for                    response to cachexia treatment? Ann Palliat Med 2019;8:43\u201349. PMID:30685983,                    https:\/\/doi.org\/10.21037\/apm.2018.12.08","DOI":"10.21037\/apm.2018.12.08"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Naito T: Evaluation of the true endpoint                    of clinical trials for cancer cachexia. Asia Pac J Oncol Nurs 2019;6:227\u2013233.                    PMID:31259217, https:\/\/doi.org\/10.4103\/apjon.apjon_68_18","DOI":"10.4103\/apjon.apjon_68_18"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. McDonald J, Sayers J, Anker SD, Arends J,                    Balstad TR, Baracos V, Brown L, Bye A, Dajani O, Dolan R, Fallon MT, Fraser E,                    Griel C, Grzyb A, Hjermstad M, Jamal-Hanjani M, Jakobsen G, Kaasa S, McMillan D,                    Maddocks M, Philips I, Ottestad IO, Reid KF, Sousa MS, Simpson MR, Vagnildhaug                    OM, Skipworth RJ, Solheim TS, Laird BJ, Cancer Cachexia Endpoints Working Group:                    Physical function endpoints in cancer cachexia clinical trials: systematic                    review 1 of the cachexia endpoints series. J Cachexia Sarcopenia Muscle                    2023;14:1932\u20131948. PMID:37671529,                    https:\/\/doi.org\/10.1002\/jcsm.13321","DOI":"10.1002\/jcsm.13321"}],"container-title":["Progress in Rehabilitation Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/prm\/11\/0\/11_20260012\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:46:24Z","timestamp":1774673184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/prm\/11\/0\/11_20260012\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":60,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2490\/prm.20260012","relation":{},"ISSN":["2432-1354"],"issn-type":[{"value":"2432-1354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"20260012"}}